| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2882559 | The Annals of Thoracic Surgery | 2007 | 5 Pages |
Abstract
For patients deemed at clinical stage I NSCLC by CT and PET, the prevalence of missed N2 metastases increased significantly with larger tumor size and central location. Adenocarcinoma cell type and a high PET SUVmax of the primary tumor were other risk factors. Mediastinoscopy may have improved yield in the select subset of patients with one or more risk factor.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul C. MD, Jeffrey L. MD, Robert J. MD, Yaakov BA, Danish N. MPH, Nasser K. MD,